Paul A Harmon

Title: Paul A Harmon: Innovator in Taxane Derivatives

Introduction

Paul A Harmon is a notable inventor based in Newtown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of taxane derivatives. With a total of five patents to his name, Harmon has focused on innovations that enhance the efficacy of cancer treatments.

Latest Patents

Harmon’s latest patents include groundbreaking inventions such as hydrophobic taxane derivatives and the preparation of liposomal taxanes. The hydrophobic taxane derivative invention provides a formula where a hydrophobic organic moiety is attached to a taxane. This attachment stabilizes the association of the derivative with lipid carriers in the plasma of animals. Additionally, the preparation of liposomal taxanes involves a composition containing the taxane derivative and a pharmaceutically acceptable medium, which is crucial for effective administration to animals afflicted with cancers.

Career Highlights

Harmon is currently associated with The Liposome Company, Inc., where he continues to innovate in the field of drug delivery systems. His work has been instrumental in advancing the understanding and application of taxane derivatives in cancer therapy.

Collaborations

Harmon has collaborated with notable colleagues such as J Craig Franklin and Andrew S Janoff. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Paul A Harmon stands out as a significant figure in the realm of pharmaceutical innovations, particularly in the development of taxane derivatives for cancer treatment. His contributions continue to impact the field positively.